Latham, New York-based AngioDynamics designed Auryon for the treatment of peripheral artery disease (PAD). That includes critical limb ischemia (CLI) and in-stent restenosis (ISR).

Auryon uses revolutionary solid-state laser technology to treat PAD lesions and occlusions effectively. AngioDynamics describes it as the first laser atherectomy system to efficiently treat lesions of any type, length or location (above and below the knee) with minimal impact on vessel walls.

The system uses a 355nm wavelength laser platform, enabling the use of short UV laser pulses with targeted biological reactions. These offer effectiveness in treating PAD while minimizing the risk of perforation. It also preserves the ability to vaporize lesions without thermal ablation.